Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(0)
# 4203
Out of 5,319 analysts
125
Total ratings
43.28%
Success rate
-11.83%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
HCAT Health Catalyst | Downgrades: In-Line | 6 4 | 3.84 | 4.17% | 6 | Apr 9, 2025 | |
FTRE Fortrea Holdings | Maintains: In-Line | 20 15 | 5.29 | 183.55% | 7 | Mar 4, 2025 | |
MCK McKesson | Maintains: Outperform | 650 675 | 697.08 | -3.17% | 5 | Feb 6, 2025 | |
ALGN Align Tech | Maintains: Outperform | 240 260 | 171.41 | 51.68% | 12 | Feb 6, 2025 | |
CVS CVS Health | Maintains: Outperform | 60 65 | 67.29 | -3.4% | 6 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 9 12 | 10.89 | 10.19% | 13 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 260 265 | 217.12 | 22.05% | 4 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 20 | 12.83 | 55.88% | 7 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 140 140 | 134.71 | 3.93% | 6 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 36 | 36.45 | -1.23% | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 8 9 | 6.83 | 31.77% | 2 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 270 265 | 143.91 | 84.14% | 5 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 34 45 | 53.21 | -15.43% | 7 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 7 4 | 4 | 0% | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 23 | 15.18 | 51.52% | 3 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: In-Line | 165 | 163.8 | 0.73% | 2 | Aug 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 23 20 | 23.68 | -15.54% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 5 5 | 2.35 | 112.77% | 3 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 12 16 | n/a | n/a | 2 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 25 39 | n/a | n/a | 2 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Outperform | 185 | n/a | n/a | 9 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 7 5 | n/a | n/a | 1 | Sep 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 12 | n/a | n/a | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 68 27 | 11.22 | 133.96% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 35 15 | 5.92 | 153.38% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: In-Line | 11 | 3.24 | 239.51% | 2 | Jan 4, 2022 |